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Abstract Streptococcal protein G (SPG) is a cell surface recep- 
tor protein with a multiple domain structure containing tandem 
repeats of serum albumin-binding domains (ABD) and immuno- 
globulin-binding domains (IgBD). In this paper, we have analysed 
the fold of ABD. Far-UV circular dichroism analysis of ABD 
indicates high helical content (56%). Based on an analysis of 
nuclear magnetic resonance ~sC secondary chemical shifts, se- 
quential and short-range NOEs, and a few key nuclear Over- 
hauser effects, we conclude that the ABD is a three-helix bundle. 
The structure of the ABD is, thus, quite different from the lgBD 
of protein G [Gronenborn, A.M. et al. (1991) Science 253, 657- 
6611. This strongly suggests that the ABD and the IgBD of SPG 
have evolved independently from each other. However, the fold 
of ABD is similar to that of the IgBD of staphylococcal protein 
A, possibly indicating a common evolutionary ancestor, despite 
the lack of sequence homology. 
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1. Introduction 
Protein G (SPG) is a multidomain protein present on the cell 
surface of Streptococcus of groups C and G. It displays binding 
to immunoglobulins from several species by interaction with 
the constant Fc region of IgG or the CH1 domain of certain 
Fab fragments [1], which is thought o help the organism evade 
the host defenses by creating a coat of host proteins [2]. A 
second activity of SPG is the binding to serum albumin from 
various species, including human serum albumin (HSA) [3,4]. 
The immunoglobulin and serum albumin-binding activities 
have been shown to reside within small and functionally sepa- 
rate domains of the SPG molecule [5,6] (Fig. la). Other bacte- 
rial surface proteins that bind immunoglobulins include protein 
A (SPA) from Staphylococcus aureus [7,8] and protein L from 
Peptostreptococcus magnus which binds to immunoglobulin 
light chains [9], while the PAB protein from P. magnus is an- 
other example of a serum albumin-binding protein [10]. 
Depending on the Streptococcus strain, SPG contains two or 
three immunoglobulin-binding domains of approximate 55 res- 
idues, denoted B1 through B3 or C1 through C3 by different 
authors [11-13] (Fig. la). 3D structures have been determined 
for single immunoglobulin-binding domains by NMR [14,15] 
and by X-ray crystallography [16,17]. In addition, also the 
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structures of SPG immunoglobulin-binding domains in com- 
plex with Fab [18] or Fc [19] have been described. The structure 
of an individual domain consists of a mixed parallel/antiparallel 
fl-sheet of four strands, with a single c~-helix packed onto the 
sheet. In contrast, NMR studies have shown that a single SPA- 
derived immunoglobulin-binding domain consists of three he- 
lices in a roughly antiparallel arrangement [20,21]. A medium- 
resolution X-ray determination f domain B of SPA in complex 
with the constant region of immunoglobulin G showed the 
presence of only the two N-terminal helices [22]. 
Since the bacterial receptors consist of multiple repetitive 
domains it is, from an evolutionary, biological and biochemical 
point of view, interesting to compare the structure of a serum 
albumin-binding domain with the known structure of the im- 
munoglobulin-binding domains present in the same SPG recep- 
tor molecule. Here, we report the assignment of the NMR ~H, 
~5N and ~3C backbone resonances and secondary structure, as 
well as a tentative model of the global fold, of one of the three 
serum albumin-binding motifs present in SPG, denoted ABD 
for albumin-binding domain. Surprisingly, the fold of ABD is 
quite different from that of the SPG immunoglobulin-binding 
domain. 
2. Materials and methods 
2.1. DNA constructions and bacterial strains 
All DNA manipulations were done essentially as described by Sam- 
brook and coworkers [23]. PCR amplifications were performed on a 
Techne PHC-II thermocycler (Techne, UK) using standard protocols 
and buffers [24]. The cloning work was done using E. coli strain 
RR1AM15 [25] as host while the production of the ~SN/L3C-labelled 
protein was done in strain RV308 [26]. 
A DNA fragment encoding a 46-residue serum albumin-binding do- 
main (ABD) derived from streptococcal protein G was PCR amplified 
from the plasmid template pTrpBB [27] using oligonucleotides MI-13: 
5'-CCGAATTCATTAGC TGAAGCTAAAGTC-3' and TCS-2: 5'- 
CCGGATCCACTAGTCTCGAGTTAAGGTA ATGCAGCTAAA- 
ATTTC-Y. The PCR product was first inserted into pRIT28 adapted 
for solid phase DNA sequencing [24]. By the use of flanking EcoRI and 
XhoI restriction sites, the ABD-encoding fragment was subsequently 
inserted into the expression vector pE318 resulting in pEABD, used for 
secreted expression and functional analysis. The pE318 vector is a 
derivative of pEZZ18 [28] in that the two IgG-binding Z domains are 
deleted through excision using flanking AccI restriction sites, followed 
by religation of the vector. Subsequently, the ABD-encoding ene was 
excised from pEABD with FspI and Xhol followed by insertion i to the 
FspI and SalI restricted expression vector pTrpBBT1T2 constructed 
from pTrpBB by insertion into the PstI and HindIII sites of the strong 
rrnB ribosomal RNA transcription terminator PCR amplified from 
pKK223-3 (Pharmacia Biotech, Sweden) using oligonucleotides 
H EAN 19: 5'-CCCCCTGCAGCTCGAGCGCTTAACTGT TTGG- 
CGGATG-3" and HEAN20: 5'-CCCCAAGCTTAGAGTTTGTAG- 
AAACGC-Y. The resulting expression vector pTrpABDTIT2, thus, 
encodes a fusion protein containing a trp operon-derived leader 
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sequence ( ight residues), region E' of staphylococcal protein A domain 
E (six residues), a cloning rest sequence (five residues) followed by the 
46 residue serum albumin-binding domain (Fig. lb). 
2.2. Production and pur(fi'cation of  l~ C/15N-labelled ABD protein 
A 0.5-ml frozen E. coli RV308 culture, harboring the expression 
vector pTrpABDT1T2, was used to inoculate 20 ml 2 z YT medium 
supplemented with kanamycin monosulfate (60 mg/1) and left to grow 
overnight at 30°C with shaking. 0.5 ml of the overnight culture was 
used to inoculate 50 ml of a totally defined medium with ]~C-glucose 
and ('5NH4)2SO4 as the only carbon and nitrogen sources, respectively. 
The medium contained: 2.5 g/1 (~SNH4hSO4 (Cambridge Isotopes Lab- 
oratory, Cambridge, MA) 5 g/l ]3C-glucose (Cambridge Isotopes Labo- 
ratory), 1 g/l MgSO4, 70 mg/l thiamine, 0.7 mg/1 Na,MoO4-2H20, 60 
mg/l kanamycin monosulfate, 1 ml/l trace elements olution (16.2 g 
FeC13"6H20, 2.4 g ZnSO4.7HzO, 4.2 g CoC1_,.6H20, 4.8 g 
CuSO 4 . 5H,O, 1.2 g H3BO 3, 3.0 g MnSO4, 30 ml HCI and 570 ml H20), 
0.65 ml/l vitamin solution (0.4 g pantothenic acid calcium salt, 0.4 g 
choline chloride, 0.4 g folic acid, 0.8 g myo-inositol, 0.4 g nicotinamid, 
0.4 g pyridoxal hydrochloride, 0.04 g riboflavin, 0.4 g thiamine hydro- 
chloride and 800 ml H20, pH adjusted to 7.2 7.4 using NaOH). Com- 
ponents listed above were added by sterile filtration. A phosphate 
buffer (9 g/l KH2PO 4, 6 g/l K2HPO4, 0.5 g/1 Na3-citrate, pH adjusted 
to 6.6) was added after autoclaving. 
The culture was grown overnight at 30°C and used to inoculate 11 
of the defined medium which was allowed to grow in two 5-1 baffled 
shake flasks at 30°C. Expression of ABD protein was induced at mid- 
log phase by adding fl-indole acrylic acid to 25 mg/1. The cultures were 
harvested after 22 h by centrifugation followed by resuspension f the 
cell pellet in TST buffer (50 mM Tris. HCI pH 7.5, 0.15 M NaCl, 0.05% 
Tween-20) prior to sonication. After clarification, the supernatant from 
the disrupted cells containing the ABD protein was applied to a HSA- 
Sepharose column [6] equilibrated with TST buffer. After extensive 
washing of the column with TST buffer followed by 5 mM ammonium 
acetate pH 5.5, the ABD protein was eluted with 0.5 M acetic acid (pH 
2.8) and lyophilized. Lyophilized ABD protein (approximately 50nag) 
was dissolved in 50 mM phosphate buffer pH 7.2 and loaded on a 16/60 
Superdex 75 prep grade size exclusion column (Pharmacia Biotech, 
Sweden) with a bed volyme of 120 ml. The running buffer was 20 mM 
phosphate pH 7.2 and the flow rate 1 ml/min. Fractions containing 
ABD protein were collected and concentrated to 2 mM using a centrif- 
ugal concentrator (Macrosept 3K, Filtron, USA). 
2.3. Protein analysis 
The degree of incorporation of ~3C and ~SN in the protein was analy- 
sed by mass pectrometry using a Fison Quattro quadrupole instrument 
equipped with an electrospray ion source. The protein was dissolved in 
a mixture of 1% formic acid, 49% water and 50% acetonitrile to a 
concentration f 20 pM and 10 ,ul was injected into a carrier stream of 
the same solvent pumped at a flowrate of 10/A/min. About 8 scans were 
accumulated in the mass range of 700 to 1700 mass units. The raw 
spectrum showed ifferent degrees of protonation from 5 to 9 charges. 
Circular dichroism (CD) spectra were collected with a J-720 spectro- 
polarimeter (JASCO, Japan) at room temperature with a scanning 
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Fig. 1. (a) Schematic drawing showing the domain structure of the 
streptococcal protein G [13]. The albumin-binding domain (ABD) 
number 3analysed in this study is indicated. (b) Sequence comparison 
of the three ABD domains of protein G from Streptococcus G148, with 
the sequences of other homologous domains: two in a protein from a 
bovine Streptococcus strain DG12 [51] and two domains in PAB from 
P magnus [10]. 
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Fig. 2. CD spectrum of ABD, overlayed with the CD spectrum of the 
Z domain of staphylococcal protein A [41]. 
speed of 20 nm/min and a cell path length of l mm by averaging over 
three scans. The protein sample concentration was 0.1 mg/ml in 20 mM 
sodium phosphate buffer at pH 7.5. The spectrum was analysed in 
terms of secondary-structure content by a variable selection procedure 
[29] using 33 reference proteins. The criteria to choose the best solutions 
(after emoving two proteins from the basis set) were: The sum of the 
predicted secondary structure should be between 0.99 and 1.00, no 
root-mean-square residual less than 0.25 epsilon units was allowed, and 
no larger negative value than -0.05 was allowed. 
2.4. NMR spectroscopy 
All NMR spectra were recorded from a single sample of gel-filtered 
ABD with a protein concentration of 2.0 mM, containing 50 mM 
sodium phosphate, 0.4% sodium azide and 10% D20. The (uncorrected) 
pH was 7.2. The gel-filtered protein sample was stored as a frozen 
solution, rather than freeze-dried. 
NMR spectra were recorded on Varian Unity 600 and 500 MHz 
spectrometers quipped with three channels and a pulsed field gradient 
triple-resonance probe with an actively shielded z gradient. The follow- 
ing spectra were recorded: ]H-'SN HSQC [30], ]HJ3C CT-HSQC [31], 
HNCO [32], HNCACB [33], CBCA(CO)NH [34], CBCA(CO)HA [35], 
3D HCC(CO)NH-TOCSY and 3D CC(CO)NH-TOCSY [36,37] and 
simultaneous [SN- and ~C-edited 3D NOESY [38]. The spectra were 
processed with the NMRPipe program (Frank Delaglio, NIDDK, 
NIH) using linear prediction in the ]SN and/or ]3C dimensions of the 
3D spectra. The spectra were assigned with the interactive graphics 
ANSIG program adapted for multidimensional heteronuclear NMR 
spectra [39,40]. 
3. Results and discussion 
The CD spectrum of the third serum albumin-binding do- 
main o fSPG (ABD) clearly shows a high c~-helical content (Fig. 
2). For comparison, the CD spectrum of the Ig-binding Z do- 
main of protein A [41] is plotted in the same graph, The compa- 
rable a-helical content of the two proteins is indicated by the 
similar amplitudes of the minimum at 208 nm, of the shoulder 
at 222 nm and of the CD maximum at 185 to 190 nm. A 
numerical analysis of the CD spectrum using a variable selec- 
tion procedure [29] gave a value of 56% c~-helix content for 
ABD, and essentially no fl-sheet structure. The Z domain of 
protein A contains 53% s-helix calculated from the 3D struc- 
ture [42]. 
Preliminary investigations of ABD indicated that the disper- 
sion of NMR chemical shifts was small, in accordance with the 
high c~-helical content found by CD. Therefore, a uniformly 
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Fig. 3. (a) Secondary chemical shifts in ABD for ~3C~ (solid line) and ~3C~ (dashed line) as a function of the sequence. The secondary chemical shift 
plots indicate the presence ofthree ~-helical segments separated by coil regions. The first 16 residues have values indicating random coil. (b) Summary 
of the sequential nd short-range NOE connectivities observed in the simultaneous t3C- and ~SN-edited 3D NOESY spectrum. The schematic coils 
at the bottom of the figure depict he locations of the three ~-helices in the sequence. 
~SNP3C-double-labelled protein sample was used for this inves- 
tigation. The measured atomic mass of the protein was 7497.0 
Da, which indicates that the incorporation of LSN and 13C was 
in excess of 98.0%. This allows the use of multidimensional 
heteronuclear NMR experiments o increase the spectral reso- 
lution. The NMR resonances were assigned using a minimal set 
of triple-resonance spectra for a problem of this size. 
The resonance assignments of the backbone and ~3C~ nuclei 
were obtained by performing a sequential walk in the 
HNCACB and CACB(CO)NH spectra. The assignment walk 
was started at several different spin systems exhibiting charac- 
teristic combinations of 13CC~/13Cfl chemical shifts. The place- 
ment of the sequential fragments in the sequence of the protein 
could usually be made unambiguously when 3 or 4 spin systems 
had been connected [43]. Occasionally, reference was made to 
the 2D HSQC spectra (IHJSN and IH-13C) and to the HNCO 
and CBCA(CO)HA spectra to interpret regions with severe 
overlap of cross-peaks. Aliasing was used in some 3D spectra 
to optimize the digital resolution, and was resolved by reference 
to the 2D HSQC spectra nd by comparison totypical chemical 
shifts in amino-acid residues [44]. The backbone assignments 
were subsequently confirmed by analysis of the HCC(CO)NH- 
TOCSY and CC(CO)NH-TOCSY spectra, which gave nearly 
complete assignments of all 1H, ~5N and ~3C nuclei n the side- 
chains. Almost all cross-peaks in all spectra were subsequently 
assigned to ensure consistency. The HN resonances of residues 
Met-1 and Lys-2 could not been assigned, presumably because 
the signals are attenuated by solvent exchange ffects. The 
resonance assignments are available upon request. 
It has been shown that the 13C chemical shifts of C ~ and C ~ 
nuclei correlate with the conformation of the backbone in pro- 
teins [45]. When the random-coil values of the C a and C ~ nuclei 
for each amino-acid residue type [46] are subtracted from the 
chemical shifts of these nuclei n the residues of the sequence, 
the remainder (the secondary chemical shift) shows a character- 
istic pattern which allows an accurate delineation ofthe second- 
ary structure in terms of a-helix, fl-strand or random coil [47]. 
To obtain further data on the secondary structure, the simulta- 
neous ~SN- and L3C-edited 3D NOESYwas investigated for the 
presence of sequential nd short-range NOEs indicative of sec- 
ondary structure. 
The secondary chemical shift as a function of the sequence 
is shown for ABD in Fig. 3a. The sequential nd short-range 
NOEs are shown in a summary in Fig 3b. This data shows 
unambigously the presence of three helices separated by turns 
or random-coil regions. The first 16 or 17 residues are in a 
random-coil structure, or more likely, are flexible in solution. 
This part of the sequence is not present in the protein G se- 
quence, but is rather derived from the cloning construct. The 
first 16 residues in the protein studied here are the same as in 
the F30A mutant [41] of the Z domain of staphylococcal pro- 
tein A [42]. The chemical shifts for these residues are essentially 
identical in the two proteins (data not shown), and the lack of 
sequential nd short-range NOEs, supports the conclusion that 
this N-terminal sequence is flexible in both proteins. The first 
helix starts at Ala-17 or Asn-18 and ends with Lys-33. The 
protein G sequence starts at Leu-20. The second helix begins 
with Asp-38 and ends with Asn-45. The third helix spans Val-50 
to Ala-62. It is possible that helix 3 continues beyond residue 
Ala-62 in the intact protein, since fraying effects at the C- 
terminal of the construct studied here may cause artifacts. The 
sharp reversal of the trend of the secondary chemical shift at 
residue Thr-49 indicates that this residue probably forms a 
so-called capping box for helix 3 [48], i.e. the main-chain amide 
group of residue Gly-52 is hydrogen-bonded to the hydroxyl 
group of Thr-49. Although the typical N-cap contains a Thr or 
Ser at position i and a Glu or Gln at residue i+3, in ABD the 
residue at i+3 is Gly, which is conserved among the different 
sequences, except in the sequence from ALB8 which does have 
a Glu at this position (Fig. lb). The region 47 Ala to 51 Glu 
(the AKTVE motif) is strictly conserved in the homologous 
sequences (Fig. lb) and this region forms most of the loop 
connecting the second and third helices. 
The preliminary analysis of the simultaneous ~3C- and 15N- 
edited 3D NOESY spectrum showed the presence of two sets 
of well-resolved, easily identified NOEs which give some infor- 
mation on the relative arrangement of the three a-helices. The 
first set involves NOEs between protons in the side-chain of 
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Fig. 4. Schematic comparison ofthe structural folds of (a) the albumin-binding domain of streptococcal protein G and (b) domain Z of staphylococcal 
protein A [42]. The relative arrangement of the a-helices in the ABD model is based on a few key NOEs and is, therefore, approximate. The overall 
chirality of the fold is not determined by the available data. The figure was generated using MolScript [52]. 
Lys-24 and the backbone of Asn-45, while the second set in- 
volves NOEs between protons in the aromatic ring of Tyr-40 
and the side-chain of Ile-60. The restraints given by these NOEs 
were used to construct a schematic model (Fig. 4a). The data 
is consistent with a roughly antiparallel bundle of a-helices. 
This model only depicts a likely arrangement of the s-helices, 
since the available data does not allow any statements about 
the exact relative angles and positions of the s-helices, nor 
about the overall chirality of the fold. 
The fold is clearly different from the IgBD of protein G, 
which has a fl-sheet of four strands with a single c~-helix packed 
onto it. However, a three-helix bundle similar to that in ABD 
is present in the IgBD of staphylococcal protein A [20,21]. A 
comparison of the amino-acid sequences of ABD with the im- 
munoglobulin-binding domain of staphylococcal protein A in- 
dicated no detectable significant sequence homology, not even 
when attempting to aid the sequence comparison with the posi- 
tions of the helices. As is evident from Fig. 4, there is, however, 
a clear structural similarity, although the lengths of the helices 
are somewhat different. 
The ABD structure is unusual in that it is a small folded 
domain of only about 45 residues, which has no additional 
stabilising features uch as bound ligands, metal ions, disulfide 
bridges, or other cross-links. There are few examples of such 
small folded domains, the IgBD of protein A being one. The 
three-helix bundles are, therefore, attractive model systems for 
experimental s well as theoretical folding studies [49]. 
It is intriguing that the HSA-binding domain of SPG has a 
similar fold as the IgBD of protein A from S. aureus, while the 
IgBD of protein G has a different fold. The two IgBDs repre- 
sent different structural solutions to the molecular ecognition 
problem for one class of target molecules. It is tempting to 
speculate that the three-helix fold of the albumin-binding do- 
main has an evolutionary relationship with the immunoglob- 
ulin-binding domain of protein A, although the sequences of 
the domains do not show any obvious traces of such a relation- 
ship. Doolittle [50] has, however, postulated that structure nor- 
mally is better conserved than sequence, why an evolutionary 
relationship might still exist. 
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